Publicaciones en colaboración con investigadores/as de GlaxoSmithKline (United Kingdom) (14)

2022

  1. Association between Hemagglutination Inhibition Antibody Titers and Protection Against Reverse-Transcription Polymerase Chain Reaction-Confirmed Influenza Illness in Children 6-35 Months of Age: Statistical Evaluation of a Correlate of Protection

    Open Forum Infectious Diseases, Vol. 9, Núm. 2

2020

  1. Quadrivalent Influenza Vaccine Prevents Illness and Reduces Healthcare Utilization Across Diverse Geographic Regions During Five Influenza Seasons: A Randomized Clinical Trial

    The Pediatric infectious disease journal, Vol. 39, Núm. 1, pp. e1-e10

2019

  1. Clinical Presentation of Influenza in Children 6 to 35 Months of Age: Findings From a Randomized Clinical Trial of Inactivated Quadrivalent Influenza Vaccine

    The Pediatric infectious disease journal, Vol. 38, Núm. 8, pp. 866-872

2018

  1. Factors influencing access of pregnant women and their infants to their local healthcare system: A prospective, multi-centre, observational study

    BMC Pregnancy and Childbirth, Vol. 18, Núm. 1

  2. Immunogenicity and safety of the quadrivalent meningococcal vaccine MenACWY-TT co-administered with a combined diphtheria-tetanus-acellular pertussis vaccine versus their separate administration in adolescents and young adults: A phase III, randomized study

    Vaccine, Vol. 36, Núm. 31, pp. 4750-4758

  3. Prevention of vaccine-matched and mismatched influenza in children aged 6–35 months: a multinational randomised trial across five influenza seasons

    The Lancet Child and Adolescent Health, Vol. 2, Núm. 5, pp. 338-349

2017

  1. Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa

    Human Vaccines and Immunotherapeutics, Vol. 13, Núm. 7, pp. 1505-1515

2013

  1. A multi-country study of intussusception in children under 2 years of age in Latin America: Analysis of prospective surveillance data

    BMC Gastroenterology, Vol. 13, Núm. 1

2011

  1. Horizontal transmission of a human rotavirus vaccine strain-A randomized, placebo-controlled study in twins

    Vaccine, Vol. 29, Núm. 51, pp. 9508-9513

  2. Human rotavirus vaccine is highly efficacious when coadministered with routine expanded program of immunization vaccines including oral poliovirus vaccine in latin america

    Pediatric Infectious Disease Journal, Vol. 30, Núm. 6

2008

  1. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study

    The Lancet, Vol. 371, Núm. 9619, pp. 1181-1189

2002

  1. DTPw-HB and Hib primary and booster vaccination: Combined versus separate administration to Latin American children

    Vaccine, Vol. 20, Núm. 13-14, pp. 1887-1893

1999

  1. Hepatitis B seroprevalence in Latin America

    Revista Panamericana de Salud Publica/Pan American Journal of Public Health, Vol. 6, Núm. 6, pp. 378-383

1998

  1. Interferon alpha treatment of chronic hepatitis C in HIV-infected patients receiving zidovudine: Efficacy, tolerance and response related factors

    Hepato-Gastroenterology, Vol. 45, Núm. 23, pp. 1695-1701